Serotonin-5-O-carboxymethyl-glycyl[125I]tyrosinamide labels the 5-HT1D beta receptor subtype in human cortex.
Eur J Pharmacol
; 242(2): 195-8, 1993 Sep 28.
Article
em En
| MEDLINE
| ID: mdl-8253115
ABSTRACT
This study, carried out in human cerebral cortical membranes, confirms previous findings in human substantia nigra that serotonin-5-O-carboxymethyl-glycyl[125I]tyrosinamide ([125I]GTI) labels a homogeneous population of recognition sites consistent with a 5-HT1D receptor pharmacology. In addition the results indicate that, under the assay conditions described, [125I]GTI specifically labels the 5-HT1D beta recognition site since ketanserin and ritanserin display a low affinity consistent with their activities at this subtype of the 5-HT1D receptor.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Serotonina
/
Córtex Cerebral
/
Receptores de Serotonina
/
Dipeptídeos
Limite:
Humans
Idioma:
En
Ano de publicação:
1993
Tipo de documento:
Article